Role of cardiac troponin I in the evaluation of myocardial injury

Autor:	Alan P. Goldstein, Cheryl E. Sugiyama, Gale K. Fujitani, Jane Uyehara, Stacey A.A. Honda, Nadhipuram V. Bhagavan, Lucille Kang, Lourna Murakami, Jodi M. Blaisdell
Rok vydání:	1998
Předmět:	Microbiology (medical) medicine.medical_specialty Cardiac troponin Clinical Biochemistry Cardiac marker Myocardial Ischemia macromolecular substances Internal medicine Troponin I medicine Immunology and Allergy Humans Myocardial infarction cardiovascular diseases Creatine Kinase Retrospective Studies L-Lactate Dehydrogenase Cardiac ischemia business.industry Biochemistry (medical) Public Health Environmental and Occupational Health Cardiac muscle Hematology Original Articles medicine.disease musculoskeletal system Lactate dehydrogenase isoenzymes Isoenzymes Medical Laboratory Technology medicine.anatomical_structure ROC Curve Cardiology cardiovascular system Kidney Failure Chronic business Biomarkers
Zdroj:	Journal of clinical laboratory analysis. 12(5)
ISSN:	0887-8013
Popis:	Cardiac troponin I (cTnI) is highly specific for cardiac muscle. In this study, we compared the utility of CK and CK‐MB index versus cTnI in the assessment of myocardial infarction in 155 patients being evaluated for myocardial damage. As a cardiac marker for MI, Troponin I seems to be superior to CK‐MB. In the subset of patients with renal disease, cTnI has definite advantages over CK‐MB. In addition, the use of cTnI has the potential to replace the measurement of lactate dehydrogenase isoenzymes. J. Clin. Lab. Anal. 12:276–279, 1998. © 1998 Wiley‐Liss, Inc.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cbde5e02fc4a6ff71f1b3b5403ae15f https://pubmed.ncbi.nlm.nih.gov/9773957 Zobrazit plný text záznamu